Literature DB >> 22185185

Health utility elicitation: is there still a role for direct methods?

Lisa A Prosser, Scott D Grosse, Eve Wittenberg.   

Abstract

Mesh：

Year:  2012        PMID： 22185185     DOI： 10.2165/11597720-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  19 in total

Review 1.  Family caregiving of persons with dementia: prevalence, health effects, and support strategies.

Authors:  Richard Schulz; Lynn M Martire
Journal:  Am J Geriatr Psychiatry       Date:  2004 May-Jun       Impact factor: 4.105

2.  Conjoint Analysis Applications in Health - How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008.

Authors:  Deborah Marshall; John F P Bridges; Brett Hauber; Ruthanne Cameron; Lauren Donnalley; Ken Fyie; F Reed Johnson
Journal:  Patient       Date:  2010-12-01       Impact factor: 3.883

3.  Too important to ignore: informal caregivers and other significant others.

Authors:  Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Using DCE and ranking data to estimate cardinal values for health states for deriving a preference-based single index from the sexual quality of life questionnaire.

Authors:  Julie Ratcliffe; John Brazier; Aki Tsuchiya; Tara Symonds; Martin Brown
Journal:  Health Econ       Date:  2009-11       Impact factor: 3.046

Review 5.  Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis.

Authors:  Scott D Grosse; Sarah Wordsworth; Katherine Payne
Journal:  Genet Med       Date:  2008-09       Impact factor: 8.822

Review 6.  Methods for measuring temporary health States for cost-utility analyses.

Authors:  Davene R Wright; Eve Wittenberg; J Shannon Swan; Rebecca A Miksad; Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

7.  Health effects in significant others: separating family and care-giving effects.

Authors:  Ana Bobinac; N Job A van Exel; Frans F H Rutten; Werner B F Brouwer
Journal:  Med Decis Making       Date:  2010-07-29       Impact factor: 2.583

8.  Caring for and caring about: disentangling the caregiver effect and the family effect.

Authors:  Ana Bobinac; N Job A van Exel; Frans F H Rutten; Werner B F Brouwer
Journal:  J Health Econ       Date:  2010-06-01       Impact factor: 3.883

9.  The association between caregiver burden and caregiver health-related quality of life in Alzheimer disease.

Authors:  C M Bell; S S Araki; P J Neumann
Journal:  Alzheimer Dis Assoc Disord       Date:  2001 Jul-Sep       Impact factor: 2.703

Review 10.  Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.

Authors:  Lisa A Prosser; James K Hammitt; Ron Keren
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981
View more
  10 in total

1.  Carer preferences in economic evaluation and healthcare decision making.

Authors:  Hareth Al-Janabi; Nikki McCaffrey; Julie Ratcliffe
Journal:  Patient       Date:  2013       Impact factor: 3.883

Review 2.  Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis.

Authors:  Scott D Grosse; Shraddha S Chaugule; Joel W Hay
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015-01-14       Impact factor: 2.217

3.  Joint Utility Estimators in Substance Use Disorders.

Authors:  Eve Wittenberg; Jeremy W Bray; Achamyeleh Gebremariam; Brandon Aden; Bohdan Nosyk; Bruce R Schackman
Journal:  Value Health       Date:  2016-11-17       Impact factor: 5.725

4.  Supporting shared decision making within the MobiGuide project.

Authors:  Silvana Quaglini; Yuval Shahar; Mor Peleg; Silvia Miksch; Carlo Napolitano; Mercedes Rigla; Angels Pallàs; Enea Parimbelli; Lucia Sacchi
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

5.  Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.

Authors:  Eve Wittenberg; Jeremy W Bray; Brandon Aden; Achamyeleh Gebremariam; Bohdan Nosyk; Bruce R Schackman
Journal:  Addiction       Date:  2015-12-17       Impact factor: 6.526

Review 6.  A systematic review of utility values for chemotherapy-related adverse events.

Authors:  Fatiha H Shabaruddin; Li-Chia Chen; Rachel A Elliott; Katherine Payne
Journal:  Pharmacoeconomics       Date:  2013-04       Impact factor: 4.981

7.  Evidence of spillover of illness among household members: EQ-5D scores from a US sample.

Authors:  Eve Wittenberg; Grant A Ritter; Lisa A Prosser
Journal:  Med Decis Making       Date:  2012-10-25       Impact factor: 2.583

Review 8.  Disutility of illness for caregivers and families: a systematic review of the literature.

Authors:  Eve Wittenberg; Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2013-06       Impact factor: 4.981

9.  SF-6D utility scores for alcohol use disorder status and alcohol consumption risk levels in the US population.

Authors:  Carolina Barbosa; Jeremy W Bray; William N Dowd; Alan Barnosky; Eve Wittenberg
Journal:  Addiction       Date:  2020-08-27       Impact factor: 6.526

10.  Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study.

Authors:  Yasuhiro Hagiwara; Takeru Shiroiwa; Kojiro Shimozuma; Takuya Kawahara; Yukari Uemura; Takanori Watanabe; Naruto Taira; Takashi Fukuda; Yasuo Ohashi; Hirofumi Mukai
Journal:  Pharmacoeconomics       Date:  2018-02       Impact factor: 4.981
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.